comparemela.com

Latest Breaking News On - Shanghai miracogen - Page 8 : comparemela.com

Synaffix Announces Expansion of Mersana License Deal to a Total Potential Value Exceeding $1 Billion

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsAnna protopapasSynaffix glycoconnectPlatform technologyMersana therapeutics incMersana therapeuticsChief executive officerKyowa kirinShanghai miracogenBiogeneration venturesBoth glycoconnect

Synaffix Announces Expansion of Mersana License Deal to a Total Potential Value Exceeding $1 Billion

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsAnna protopapasSynaffix glycoconnectPlatform technologyMersana therapeutics incMersana therapeuticsChief executive officerKyowa kirinShanghai miracogenBiogeneration venturesBoth glycoconnect

Synaffix Wins World ADC Award for Poster on Efficacy and Tolerability Data on SYNtecan E™-Based ADCs

/PRNewswire/ Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug.

Noord hollandInnovent biologicsPrnewswire synaffixHanson wadeExatecan syntecanPlatform technologyBest posterShow excellent in vivo efficacyMersana therapeuticsShanghai miracogenBiogeneration venturesBoth glycoconnect

Antibody Drug Conjugates Global Market Report 2021

/PRNewswire/ Market to grow and reach $6.12 billion in 2025 according to the "Antibody Drug Conjugates Global Market Report 2021" report that has been added.

United statesUnited kingdomOxford biotherapeuticsConcortis biotherapeuticsAstellas pharma agensysLaura woodHeidelberg pharmaDaiichi sankyo companySeattle genetics technologyTakeda pharmaceutical companyProgenics pharmaceuticalsPfizer incAbbvie incOffice of pharmaceutical qualityRoche ltdBayer ag

Antibody Drug Conjugates Global Market Report 2021

/PRNewswire/ Market to grow and reach $6.12 billion in 2025 according to the "Antibody Drug Conjugates Global Market Report 2021" report that has been added.

United statesUnited kingdomOxford biotherapeuticsConcortis biotherapeuticsAstellas pharma agensysLaura woodHeidelberg pharmaDaiichi sankyo companySeattle genetics technologyTakeda pharmaceutical companyProgenics pharmaceuticalsPfizer incAbbvie incOffice of pharmaceutical qualityRoche ltdBayer ag

vimarsana © 2020. All Rights Reserved.